U.S. Leisure Stock News

If you are wondering whether Markel Group's current share price lines up with its underlying worth, you are not alone. This article will focus squarely on what that price might imply about value. With the stock recently closing at US$2,066.97 and returns of 9.5% over 1 year, 55.4% over 3 years and 86.8% over 5 years, shorter term moves such as a 0.8% decline over 7 days, a 1.9% gain over 30 days and a 3.0% decline year to date can look quite different depending on how you judge...

Critical Metals (CRML) is back in focus after reporting its strongest rare earth assay results yet from the Hill Deposit at the Tanbreez project, even as insiders move to sell around 2.8 million shares. See our latest analysis for Critical Metals. Despite the insider selling and shelf registration, traders have focused on the Tanbreez assay update. Critical Metals’ 1 day share price return of 4.07% and 7 day share price return of 15.01% stand against a 30 day share price return of negative...

If you are wondering whether Ionis Pharmaceuticals' share price still reflects good value after a strong run, this article walks through what the current market price might be implying. The stock most recently closed at US$85.45, with returns of 5.0% over 7 days, 6.4% over 30 days, 7.3% year to date, 168.3% over 1 year, 138.0% over 3 years and 54.5% over 5 years, which naturally raises questions about future risk and reward. Recent news flow around Ionis has continued to focus on its role in...

Synopsys recently appointed former Deloitte executive Peter A. Shimer to its board and Audit Committee, while deciding not to renominate two existing directors as part of ongoing board refreshment. Shimer’s long tenure overseeing finance and operations at Deloitte and his leadership in AI-focused cancer research signal an increased emphasis on financial oversight and advanced AI-related governance at Synopsys. We’ll now examine how the trade secrets lawsuit and related investigation may...

Buyback completions put DaVita’s capital return in focus DaVita (DVA) has just wrapped up two sizeable share repurchase authorizations, a move that is drawing fresh attention to how the kidney care provider is using its balance sheet to return cash to shareholders. See our latest analysis for DaVita. At a share price of $150.91, DaVita’s recent buyback completions sit alongside a 30 day share price return of 39.58% and a three year total shareholder return of 83.45%. This suggests that...

In recent weeks, Liberty Energy Inc. has reported another strong quarter of free cash flow, enhanced its capital return program, upsized a US$500,000,000 convertible senior notes offering to US$700,000,000 due 2031, amended its credit agreement for up to US$600,000,000 in bridge financing, and saw Director Murti Arjun N. purchase 9,695.559 shares. Together, these funding moves and insider buying highlight how Liberty is reinforcing balance sheet flexibility while signaling internal...

In February 2026, Expro Group Holdings reported its fourth-quarter and full-year 2025 results, issued 2026 revenue guidance of US$360 million–US$370 million for the first quarter and US$1.60 billion–US$1.65 billion for the year, and authorized a new share repurchase program of up to US$100 million through December 31, 2026. Alongside steady full-year earnings and a 22% adjusted EBITDA margin in the fourth quarter, Expro highlighted a US$2.50 billion backlog that enhances revenue visibility...

If you are wondering whether PicS is attractively priced at its recent levels, this article will walk through what the current numbers are really saying about the stock. The share price recently closed at US$16.81, with a 7 day return of 27.4% and a year to date return of an 11.5% decline. This has caught the attention of investors who are considering the balance between growth potential and risk. Recent news coverage around PicS has focused on its positioning within the diversified...

What recent returns say about Biohaven (BHVN) Biohaven (BHVN) has had a mixed run recently, with a 2.4% gain over the past day, a 3.3% rise over the past week, a 12.2% decline over the past month, and a 25.1% gain over the past 3 months. Over longer periods, the stock shows a 9.4% year to date return, a 67.4% decline over the past year, and a 22.4% negative total return over 3 years, giving investors a wide range of outcomes to weigh. See our latest analysis for Biohaven. With the latest...

Estée Lauder Companies (EL) is back in focus after quarterly earnings and revenue topped expectations, alongside the debut of Balmain Beauty’s Destin de Balmain fragrance and ongoing moves in the growing Halal cosmetics segment. See our latest analysis for Estée Lauder Companies. The recent earnings beat, Balmain Beauty launch and focus on Halal offerings come after a 90 day share price return of 23.04% and a 1 year total shareholder return of 56.89%, while longer term total shareholder...

Riot Platforms has recently shifted its focus from primarily Bitcoin mining to building AI-focused data centers, including a 10-year US$1.00 billion lease agreement with AMD at its Rockdale, Texas site and an upcoming 2025 earnings call under scrutiny from activist investor Starboard Value. An interesting angle is Starboard’s push for Riot to accelerate this AI pivot, arguing it could unlock very large incremental value compared with its legacy mining model. We’ll now examine how the AMD...

Why Veeco Instruments (VECO) Is On Investors’ Radar Today Veeco Instruments (VECO) has drawn investor attention after recent trading, with the stock showing a 2.2% move over the past day and mixed performance across the week, month, and past 3 months. See our latest analysis for Veeco Instruments. The recent 2.2% one-day share price gain to US$29.36 comes after a weaker patch, with a 7-day share price return showing a 14.53% decline and a year-to-date share price return showing a 3.86%...

Illumina (NasdaqGS:ILMN) introduced TruPath Genome, a whole genome sequencing solution designed to improve accuracy, workflow efficiency, and cost effectiveness. The company also outlined an 18 month innovation roadmap for its NovaSeq X system, targeting gains in speed, data quality, and flexibility. These announcements expand Illumina's offering for applications such as rare disease research, oncology, and complex genomic studies. Illumina is a key player in DNA sequencing instruments and...

Sonoco Products Company recently reported past fourth-quarter 2025 results with sales of US$1,767.98 million and net income of US$332.24 million, alongside full-year 2025 sales of US$7.52 billion and net income of US$1.00 billion. The company paired this improved profitability with 2026 net revenue guidance of US$7.25 billion to US$7.75 billion, a newly appointed finance-focused independent director, and the continuation of its century-long, rising dividend record. We’ll now examine how this...

Linde plc recently announced that its Board of Directors approved a 7% increase in the quarterly dividend to US$1.60 per share, marking the 33rd consecutive year of quarterly dividend growth and payable on March 26, 2026 to shareholders of record as of March 11, 2026. This extended dividend growth streak, supported by a record US$10.00 billion project backlog and growing exposure to areas like space launch propellants, reinforces the company’s role as a long-term income and...

Pamela Seymon and former CEO Sharmistha Dubey plan to leave Match Group's Board at the 2026 Annual Meeting. The departures will change the board composition at NasdaqGS:MTCH and affect its governance structure. Investors are watching for how these board changes may influence oversight and long term company direction. Match Group, the parent of several online dating platforms, sits at the center of how people form relationships through digital services. As user behavior, regulation, and...

Itron, Inc. recently reported fourth-quarter 2025 results showing revenue of US$571.66 million and net income of US$101.63 million, and subsequently priced a US$700.00 million 0.00% convertible senior notes offering due 2032, with plans to repay its 2026 notes and repurchase about US$100.00 million of common stock. Management highlighted margin expansion, a 27% increase in sales pipeline and very large growth in Outcomes backlog, while the capped call structure on the new convertible notes...

In February 2026, Toast, Inc. reported past fourth-quarter 2025 revenue of US$1.63 billion and net income of US$101 million, with full-year revenue of US$6.15 billion and net income of US$342 million, all higher than the prior year. The company also surpassed US$2 billion in annual recurring revenue and expanded its platform with over 30,000 new locations, major restaurant brands, and an international launch in Australia. We’ll now examine how Toast’s strong jump in profitability and...

In recent weeks, Blackstone has reportedly moved into the final stages of a roughly US$2.5 billion acquisition of US-based home services provider Champions Group and joined other large investors in preparing bids for a controlling stake in Welspun New Energy at an estimated US$250 million valuation. These deals highlight Blackstone's interest in both resilient residential services and India’s expanding clean-energy infrastructure, reinforcing its multi-sector deployment of substantial...

Archrock, Inc. has reported past fourth-quarter 2025 results showing sales of US$327.09 million and revenue of US$377.07 million, with net income rising to US$116.77 million and diluted earnings per share from continuing operations reaching US$0.67. For 2025 as a whole, Archrock’s considerable uplift in sales, revenue, and net income versus the prior year highlights a step-change in profitability and operating scale that could influence how investors assess the company’s earnings power. With...

In recent days, Intel Capital joined a more than US$350 million Series E funding round for AI chip maker SambaNova Systems, while Intel and SambaNova signed a multi‑year collaboration to pair SambaNova’s new SN50 inference chip with Intel’s Xeon processors and GPUs for high-performance, lower-cost AI inference solutions. This partnership underlines Intel’s effort to strengthen its AI ecosystem and compete more directly with Nvidia and AMD by combining external innovation with its own...

Recent commentary around Trane Technologies (TT) is focusing less on short term construction cycles and more on its recurring revenue engine, as investors reassess the HVAC group as a subscription style cash flow story. See our latest analysis for Trane Technologies. The recent focus on Trane’s subscription style economics has arrived alongside strong share price momentum, with a 30 day share price return of 20.07% and year to date share price return of 16.52%, backed by a 1 year total...

Ultragenyx Pharmaceutical recently announced that the FDA accepted for review, with Priority Review, its Biologics License Application for DTX401 gene therapy to treat Glycogen Storage Disease Type Ia, supported by data from 52 patients and up to six years of follow-up. This move positions Ultragenyx to potentially introduce the first pharmacologic therapy targeting the underlying cause of GSDIa, leveraging its new U.S.-based gene therapy manufacturing facility and multiple regulatory...

Martin Marietta Materials (NYSE:MLM) has closed an asset exchange with Quikrete Holdings involving aggregates, cement, ready-mix, and nonoperating land assets. The deal shifts NYSE:MLM further toward an aggregates-led product mix and adds cash to the balance sheet. The transaction covers operations in multiple regions and is described by the company as a key part of its SOAR 2025 plan. Management frames the exchange as a step toward greater earnings durability, added financial flexibility,...